KIT and gastrointestinal stromal tumor: Due to these other activities, imatinib is effective at treating gastrointestinal stromal tumors (GIST) which are dependent on c-KIT, many other cancers, and steroid refractory Graft-versus-Host disease which requires PDGFRA activity67.